Legal & General Group PLC Sana Biotechnology, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 165,124 shares of SANA stock, worth $706,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,124

Previous 107,647 53.39%

Holding current value

$706,730

Previous $1.08 Million 16.26%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.23 - $10.44 $300,604 - $600,059	57,477 Added 53.39%	165,124 $901,000
Q1 2024 Jul 01, 2024	BUY	$4.2 - $11.27 $24,792 - $66,526	5,903 Added 5.8%	107,647 $1.08 Million
Q1 2024 May 14, 2024	BUY	$4.2 - $11.27 $49,547 - $132,952	11,797 Added 13.12%	101,744 $1.02 Million
Q3 2023 Nov 14, 2023	SELL	$3.77 - $6.23 $3,294 - $5,445	-874 Reduced 0.96%	89,947 $348,000
Q2 2023 Aug 14, 2023	BUY	$3.22 - $7.53 $67,014 - $156,714	20,812 Added 29.73%	90,821 $541,000
Q1 2023 May 15, 2023	BUY	$3.11 - $4.92 $7,597 - $12,019	2,443 Added 3.62%	70,009 $228,000
Q3 2022 Nov 14, 2022	BUY	$5.58 - $9.04 $10,401 - $16,850	1,864 Added 2.84%	67,566 $406,000
Q2 2022 Aug 22, 2022	BUY	$4.12 - $9.35 $41,134 - $93,350	9,984 Added 17.92%	65,702 $422,000
Q1 2022 May 16, 2022	BUY	$5.24 - $15.58 $193,984 - $576,771	37,020 Added 197.99%	55,718 $461,000
Q4 2021 Feb 14, 2022	BUY	$15.18 - $23.15 $138,745 - $211,591	9,140 Added 95.63%	18,698 $290,000
Q3 2021 Nov 15, 2021	BUY	$16.29 - $25.88 $99,303 - $157,764	6,096 Added 176.08%	9,558 $215,000
Q2 2021 Aug 12, 2021	BUY	$16.65 - $32.14 $2,497 - $4,821	150 Added 4.53%	3,462 $68,000
Q1 2021 May 17, 2021	BUY	$23.04 - $43.5 $76,308 - $144,072	3,312 New	3,312 $111,000

Others Institutions Holding SANA

# of Institutions

163

Shares Held

121M

Call Options Held

811K

Put Options Held

1.02M

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $814M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Sana Biotechnology, Inc. Transaction History